|
|
Volumn 19, Issue 2, 2002, Pages 95-105
|
|
Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: A case-control study
a
a
a
a
a
|
|
Author keywords
Anemia; Epoetin alfa; Hemoglobin; Pediatric oncology
|
|
Indexed keywords
RECOMBINANT ERYTHROPOIETIN;
ANTIANEMIC AGENT;
ANTINEOPLASTIC AGENT;
HEMOGLOBIN;
PLATINUM DERIVATIVE;
ADOLESCENT;
ARTICLE;
BLOOD TRANSFUSION;
CHILD;
CLINICAL ARTICLE;
DEEP VEIN THROMBOSIS;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
DRUG EFFICACY;
DRUG SAFETY;
ERYTHROCYTE TRANSFUSION;
FEMALE;
HUMAN;
MALE;
MUCOSA INFLAMMATION;
PROGNOSIS;
SEPSIS;
SOLID TUMOR;
THROMBOCYTE TRANSFUSION;
VEIN OCCLUSION;
ANEMIA;
CASE CONTROL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG INTERACTION;
INFANT;
NEOPLASM;
PHARMACOKINETICS;
PRESCHOOL CHILD;
TIME;
UTILIZATION REVIEW;
ADOLESCENT;
ANEMIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLOOD TRANSFUSION;
CASE-CONTROL STUDIES;
CHILD;
CHILD, PRESCHOOL;
DRUG INTERACTIONS;
EPOETIN ALFA;
FEMALE;
HEMATINICS;
HEMOGLOBINS;
HUMAN;
INFANT;
MALE;
NEOPLASMS;
PLATINUM COMPOUNDS;
SUPPORT, NON-U.S. GOV'T;
THERAPEUTIC EQUIVALENCY;
TIME FACTORS;
HUMANS;
|
|
EID: 0035999113
PISSN: 08880018
EISSN: None
Source Type: Journal
DOI: 10.1080/08880010252825687 Document Type: Article |
|
Times cited : (19)
|
|
References (27)
|
